This study examines the global evolution of scientific understanding regarding radon exposure and its health implications, focusing on the transition from early occupational exposure limits and epidemiological risk assessments to molecular-level attributions of radon-induced diseases. Since the early 1990s, advancements in genetic and molecular research have provided growing evidence suggesting that radon exposure may leave a distinct oncological signature, potentially allowing for more precise differentiation between radon-induced lung cancers and those caused by other factors. While this field continues to evolve, its implications extend beyond epidemiological risk assessment to include legal, medical, and regulatory frameworks. Beyond lung cancer, contemporary research has explored links between radon exposure and a range of other oncological and non-oncological diseases, including leukemia, kidney cancer, neurodegenerative disorders, and chronic respiratory conditions. The study further explores the ethical and legal consequences of these findings, particularly in the context of risk governance, compensation claims, and occupational health regulations. The paper also examines the hybrid nature of radon as both naturally occurring and anthropogenically intensified hazard, complicating risk perception and public policy responses. Additionally, the phenomenon of "contaminated communities," is discussed, wherein prolonged radon exposure disrupts social structures and contributes to psychological distress, economic losses, and legal disputes. By analyzing radon exposure through the lens of toxic disaster theory, this study outlines the sequential stages of public and regulatory responses, from initial scientific uncertainty to regulatory intervention and societal adaptation. The findings highlight a broader challenge in environmental health governance: how scientific advancements are integrated into public health policies amid economic and political constraints. Ultimately, the study underscores the need for continuous scientific inquiry and proactive policymaking to address the full spectrum of health risks associated with radon exposure.

Niniejsze opracowanie ma na celu zidentyfikowanie problemów prawnych związanych z obowiązkiem raportowania zrównoważonego rozwoju, które wynikają z unormowań zawartych w aktach prawnych Unii Europejskiej w zestawieniu z ograniczeniem prawa do informacji o środowisku i jego ochronie na podstawie przepisów krajowych. Omówiono treść obowiązku raportowania, wskazano, które podmioty mu podlegają, oraz streszczono generalne zasady sprawozdawczości zgodnie z dyrektywą CSRD. Następnie przeanalizowano prawo do informacji o środowisku i jego ochronie pod kątem zakresu przedmiotowego i podmiotowego, odwołując się do Konstytucji RP, a także do ustawy o udostępnianiu informacji o środowisku i jego ochronie, udziale społeczeństwa w ochronie środowiska oraz o ocenach oddziaływania na środowisko. W tym kontekście odpowiedziano na pytanie o wpływ ograniczenia prawa do informacji o środowisku i jego ochronie na realizację obowiązku raportowania dotyczącego zrównoważonego rozwoju.

The state's purchasing policy is one of the new institutions of the Public Procurement Law. Influenced by the changes in the package of directives coordinating public procurement procedures in 2014, our national legislator has taken steps to use public procurement for purposes other than strictly purchasing. Therefore, the authors' considerations strive to define the concept of "purchasing policy of the state", outlining the role and scope thereof in the functioning of the modern state. Furthermore, the authors try to point out problems related to its implementation by the public authorities, stating finally that purchasing policy will only be effectively implemented if all participants of the public procurement market are aware of the policy objectives.

This paper conducts an audit of the definitional layer of the Polish Atomic Law through the lens of legislative drafting principles and the terminology of the Directive 2013/59/Euratom. It demonstrates that the unusually extensive glossary of the Atomic Law is structurally fragmented across the general definitions in Article 3 and multiple chapter-specific glossaries, including cases where technical concepts are defined only for specified chapters of this Act while operating throughout its normative framework. The analysis further shows that parallel “general” and “special” definitions within a single statute may destabilize interpretative reconstruction. The article also identifies a multilingual defect in the Polish-language version of the Directive concerning the clearance/exemption distinction, and highlights additional scope-sensitive divergences in Polish transposition (natural radiation; dose limit). These findings underscore the regulatory costs of definitional inconsistency for legal certainty and the uniform application of Euratom standards.

Alpha-1 adrenergic receptor antagonists are widely used in the management of lower urinary tract symptoms, where they can induce ejaculatory dysfunction as a pharmacodynamic effect, particularly with α1A-selective agents. This observation has led to growing interest in their potential role as non-hormonal male contraceptives. This narrative review evaluates current clinical and preclinical evidence regarding the impact of α-blockers on the ejaculatory mechanism, with a focus on their potential application in male contraception. Both human and animal data were examined to contextualize the mechanistic basis for contraceptive potential. Evidence from clinical and pharmacological studies indicates that inhibition of α1-adrenoceptor-mediated smooth-muscle contraction in tissues involved in seminal emission, including the vas deferens, seminal vesicles, and prostate, can impair the emission phase of ejaculation. Agents such as tamsulosin and silodosin have been reported to induce anejaculation or markedly reduce semen volume, providing pharmacodynamic evidence of impaired seminal emission; however, these effects should not be considered equivalent to demonstrated contraceptive efficacy. Prospective clinical evidence currently includes one prospective pilot study and one randomized placebo-controlled clinical trial evaluating silodosin as a potential reversible non-hormonal male contraceptive. The prospective evidence includes marked and progressive suppression of sperm output and semen volume with repeated silodosin administration; at week 12, 94% of participants achieved a total sperm count ≤ 1 × 10⁶ per ejaculate, while the observed pregnancy incidence was 4% versus 17% with placebo. However, the available evidence remains insufficient to establish reliable contraceptive effectiveness for individual sexual exposures. Safety considerations, including cardiovascular effects and sexual dysfunction, also remain insufficiently characterized in healthy men. α1-adrenoceptor antagonists represent a biologically plausible pharmacologic strategy for male non-hormonal contraception by interfering with seminal emission and sperm delivery without directly suppressing spermatogenesis. Further pharmacokinetic–pharmacodynamic studies and rigorously designed multicentre clinical trials are required to determine the optimal dosing strategy, completeness and consistency of seminal emission suppression, contraceptive effectiveness, safety, acceptability, and reversibility of this approach.

The functioning of forest districts in Poland should be based on their mutual cooperation with local authorities in order to achieve social interest, one of the examples of which is construction or reconstruction of roads. Due to the fact that achieving mutual investments encounter real legal problems arising from underspecified and unclear concepts, an assessment should be made of whether the construction and reconstruction of forest roads is a public purpose and also answer, what is a forest and forest road within the meaning of the provisions of the Act. It is necessary to present views of legal science and jurisdiction of administrative courts. The judicial direction of administrative courts is not beneficial for achieving investments; it does not even take into account that one of the investors’ purposes – forest districts – is nature management. Presenting the contrary argumentation to judicature positions should help courts make a proper assessment in the interpretation of provisions.